Radiopharm Theranostics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 4 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2023 | Jun2024 | Jun2025 | Jun2026 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | -34.54M | -0.26M | -38.14M | -0.71M |
| Share-based CompensationStock Comp. | -3.04M | -2.64M | -1.90M |